Advanced Pharma CR, LLC ( Site 0001)

Miami, Florida 33147

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 2, Hepatic Impairment, Hypercholesterolaemia, Non-alcoholic Steatohepatitis

Studies at this site

• Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003) — Completed
• A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014) — Completed
• Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020) — Completed